Highlights
NASDAQ: ONCS       Oncosec Medical
Last Price Today's Change   Day's Range   Trading Volume
2.18   -0.05 (2.24%)  2.11 - 2.43  85,944

Overview

 
Avg Volume (4 weeks):385,315
4 Weeks Range:1.51 - 2.66
4 Weeks Price Volatility (%):
58.26%
52 Weeks Range:1.039 - 3.01
52 Weeks Price Volatility (%):
57.89%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3745  1934  355  2916 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CETX 2.57+1.623 
 VISL 0.377+0.083 
 AVP 5.60-0.05 
 DGLY 2.42+1.30 
 AESE 4.80+2.35 
 AABA 19.630.00 
 TGE 22.39+0.81 
 PFE 35.00-3.19 
 AKRX 0.09-0.094 
 NCLH 16.903+1.243 
Partners & Brokers